SINGAPORE (June 19): Trendlines Group announced that its portfolio company, Arcuro Medical, has received regulatory clearance from the United States Food and Drug Administration (FDA) for its SuperBall meniscus repair system.

This comes after Arcuro completed an extensive and successful series of pre-clinical studies in the US and Israel.

Superball is an all-suture meniscus repair system that preserves knee functionality that is secure, reliable, and effective.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook